Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Tumor protein p53 (TP53) is the most frequently mutated gene in cancer1,2. In patients with myelodysplastic syndromes (MDS), TP53 mutations are associated with high-risk disease3,4, rapid transformation to acute myeloid leukemia (AML)5, resistance to conventional therapies6,7,8 and dismal outcomes9....

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Bernard, E, Nannya, Y, Hasserjian, RP, Boultwood, J, Pellagatti, A
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	Springer Nature 2020

Ижил төстэй зүйлс

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
-н: Fidler, C, зэрэг
Хэвлэсэн: (2004)

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
-н: Ramy Rahmé, зэрэг
Хэвлэсэн: (2023-04-01)

Rare case of myelodysplastic syndrome with near-tetraploidy and TP53 mutation
-н: Čolović Nataša, зэрэг
Хэвлэсэн: (2023-01-01)

Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes
-н: Lijuan Zhang, зэрэг
Хэвлэсэн: (2023-12-01)

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
-н: Haase, D, зэрэг
Хэвлэсэн: (2019)

SF3B1 mutant myelodysplastic syndrome: Recent advances
-н: Pellagatti, A, зэрэг
Хэвлэсэн: (2020)

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
-н: Pimjai Niparuck, зэрэг
Хэвлэсэн: (2021-10-01)

Gene expression profiling in the myelodysplastic syndromes.
-н: Pellagatti, A, зэрэг
Хэвлэсэн: (2005)

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
-н: Pellagatti, A, зэрэг
Хэвлэсэн: (2016)

Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency
-н: Davidson Zhao, зэрэг
Хэвлэсэн: (2023-03-01)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
-н: Boultwood, J, зэрэг
Хэвлэсэн: (2014)

TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: biology, current therapy, and future directions
-н: Daver, NG, зэрэг
Хэвлэсэн: (2022)

Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple TP53 alterations
-н: Laurence Lodé, зэрэг
Хэвлэсэн: (2018-01-01)

Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis
-н: Rashmi Kanagal-Shamanna, зэрэг
Хэвлэсэн: (2021-03-01)

A tale of two alleles: TP53 and transformation in MPNs
-н: Brierley, C, зэрэг
Хэвлэсэн: (2022)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
-н: Liberante, F, зэрэг
Хэвлэсэн: (2013)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation.
-н: Liberante, F, зэрэг
Хэвлэсэн: (2013)

Transplantation for therapy-related, TP53-mutated myelodysplastic syndrome – not because we can, but because we should
-н: Corey Cutler
Хэвлэсэн: (2017-12-01)

Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports
-н: Fernando Barroso Duarte, зэрэг
Хэвлэсэн: (2017-05-01)

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
-н: Armstrong, R, зэрэг
Хэвлэсэн: (2017)

Bladder Myeloid Sarcoma with TP53 mutated Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap syndrome: Response to Decitabine-Venetoclax regimen
-н: Nikeeta Mandhan, зэрэг
Хэвлэсэн: (2022-01-01)

Clonality in the myelodysplastic syndromes.
-н: Boultwood, J, зэрэг
Хэвлэсэн: (2001)

To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia
-н: David A. Sallman
Хэвлэсэн: (2020-06-01)

PB1913: SYNERGISTIC EFFECTS OF DECITABINE AND APR-246 IN TP53 P.248Q-MUTATED MYELODYSPLASTIC SYNDROME
-н: Y. Fang, зэрэг
Хэвлэсэн: (2022-06-01)

Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions
-н: Shyam A. Patel, зэрэг
Хэвлэсэн: (2023-11-01)

Pulmonary infection associated with immune dysfunction is associated with poor prognosis in patients with myelodysplastic syndrome accompanied by TP53 abnormalities
-н: Yi Chen, зэрэг
Хэвлэсэн: (2023-11-01)

Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia
-н: Kathy L. McGraw, зэрэг
Хэвлэсэн: (2016-08-01)

Molecular pathogenesis of the myelodysplastic syndromes
-н: Boultwood, J, зэрэг
Хэвлэсэн: (1999)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
-н: Boultwood, J, зэрэг
Хэвлэсэн: (2012)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
-н: Melania Tesio
Хэвлэсэн: (2023-02-01)

Telomere length in myelodysplastic syndromes.
-н: Boultwood, J, зэрэг
Хэвлэсэн: (1995)

Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia
-н: Nabih Maslah, зэрэг
Хэвлэсэн: (2020-06-01)

Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study
-н: Yuxin Wang, зэрэг
Хэвлэсэн: (2022-07-01)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
-н: Pellagatti, A, зэрэг
Хэвлэсэн: (2003)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
-н: Haiwei Wang, зэрэг
Хэвлэсэн: (2022-06-01)

The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia
-н: Doolittle, H
Хэвлэсэн: (2017)

Genomic Characterization of TP53–Wild-Type Esophageal Carcinoma
-н: Alexander Quaas, зэрэг
Хэвлэсэн: (2019-01-01)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
-н: Pellagatti, A, зэрэг
Хэвлэсэн: (2008)

P066: Variant overlooked: A partial deficiency TP53 allele that skirts interpretation criteria
-н: Lisa Lansdon, зэрэг
Хэвлэсэн: (2023-01-01)

Clinical and biological implications of driver mutations in myelodysplastic syndromes.
-н: Papaemmanuil, E, зэрэг
Хэвлэсэн: (2013)